Inventor
DANENBERG KATHLEEN D
US21 patents
⚠️ This page may combine multiple inventors who share the name “DANENBERG KATHLEEN D”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
RESPONSE GENETICS INC
13 patentsUS6602670B2Aug 5, 2003
Method of determining a chemotherapeutic regimen based on ERCC1 expression
RESPONSE GENETICS INC103 citations97
US6582919B2Jun 24, 2003
Method of determining epidermal growth factor receptor and HER2-neu gene expression and correlation of levels thereof with survival rates
RESPONSE GENETICS INC123 citations97
US7132238B2Nov 7, 2006
Method of determining a chemotherapeutic regimen based on ERCC1 expression
RESPONSE GENETICS INC23 citations92
US7049059B2May 23, 2006
Method of determining a chemotherapeutic regimen based on ERCC1 and TS expression
RESPONSE GENETICS INC25 citations92
US6518416B1Feb 11, 2003
Method of determining a chemotherapeutic regimen based on ERCC1 expression
RESPONSE GENETICS INC15 citations92
US6573052B2Jun 3, 2003
Method of determining a chemotherapeutic regimen based on ERCCI expression
RESPONSE GENETICS INC13 citations83
US7732144B2Jun 8, 2010
Method of determining a chemotherapeutic regimen based on ERCC1 and TS expression
RESPONSE GENETICS INC4 citations73
US6686155B2Feb 3, 2004
Method of determining a chemotherapeutic regimen based on glutathione-S-transferase pi expression
RESPONSE GENETICS INC5 citations73
US7560543B2Jul 14, 2009
Method of determining a chemotherapeutic regimen based on ERCC1 and TS expression
RESPONSE GENETICS INC2 citations62
US7138507B2Nov 21, 2006
Method of determining a chemotherapeutic regimen based on glutathione-s transferase pi expression
RESPONSE GENETICS INC2 citations62
US6956111B2Oct 18, 2005
Method of determining dihydropyrimidine dehydrogenase gene expression
RESPONSE GENETICS INC2 citations62
US6905821B2Jun 14, 2005
Method of determining Dihydropyrimidine dehydrogenase gene expression
RESPONSE GENETICS INC2 citations62
US8026062B2Sep 27, 2011
Method of determining a chemotherapeutic regimen by assaying gene expression in primary tumors
RESPONSE GENETICS INC0 citations51
UNIV SOUTHERN CALIFORNIA
3 patentsUS6331393B1Dec 18, 2001
Process for high-throughput DNA methylation analysis
UNIV SOUTHERN CALIFORNIA379 citations96
US7960147B2Jun 14, 2011
Quantitative measurement of gene expression based on isolation of RNA from formalin-fixed paraffin-embedded tissue specimens
UNIV SOUTHERN CALIFORNIA4 citations72
US7998707B2Aug 16, 2011
Quantitative measurement of gene expression from fixed paraffin embedded tissue
UNIV SOUTHERN CALIFORNIA0 citations51